Trastuzumab withdrawal or discontinuation (4–8 weeks) can cure systolic dysfunction in the early phases of trastuzumab-induced cardiotoxicity, allowing the initiation of normal heart failure treatment (ACE inhibitors and beta-blockers) (Table 6)83. Here, ACE is linked to heart failure.